Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Haber

Showing results (141-150 of 186) with videos related to

Pageof 19
Sort By:
Leukemia|January 4, 2020
OT-82, a novel anticancer drug candidate that targets the strong dependence of hematological malignancies on NAD biosynthesisLioubov Korotchkina, Denis Kazyulkin, Pavel G Komarov, et al.
Scientific Reports|March 7, 2023
Histone H3-wild type diffuse midline gliomas with H3K27me3 loss are a distinct entity with exclusive EGFR or ACVR1 mutation and differential methylation of homeobox genesPamela Ajuyah, Chelsea Mayoh, Loretta M S Lau, et al.
Blood|April 5, 2024
Loss of the stress sensor GADD45A promotes stem cell activity and ferroptosis resistance in LGR4/HOXA9-dependent AMLNunki Hassan, Hangyu Yi, Bilal Malik, et al.
Leukemia|December 19, 2019
Effective targeting of NAMPT in patient-derived xenograft models of high-risk pediatric acute lymphoblastic leukemiaKlaartje Somers, Kathryn Evans, Leanna Cheung, et al.
Cancer Biology & Therapy|October 10, 2018
Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancerMaria Tsoli, Carol Wadham, Mark Pinese, et al.
Journal of the National Cancer Institute|July 30, 2011
ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug effluxMichelle J Henderson, Michelle Haber, Antonio Porro, et al.
Oncotarget|December 10, 2015
Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastomaAnneleen Decock, Maté Ongenaert, Robrecht Cannoodt, et al.
Frontiers in Oncology|June 9, 2022
The Combination of Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Delays KMT2A-Rearranged Leukemia ProgressionLin Xiao, Mawar Karsa, Emma Ronca, et al.
Cancer Research|December 15, 2018
Macrophage-Derived IL1β and TNFα Regulate Arginine Metabolism in NeuroblastomaLivingstone Fultang, Laura D Gamble, Luciana Gneo, et al.
Cancer Cytopathology|May 27, 2021
The important role of routine cytopathology in pediatric precision oncologyJinhan Xie, Amit Kumar, M Emmy M Dolman, et al.
Pageof 19

Showing results (141-150 of 186) with videos related to

Sort By:
Pageof 19
Leukemia|January 4, 2020
OT-82, a novel anticancer drug candidate that targets the strong dependence of hematological malignancies on NAD biosynthesisLioubov Korotchkina, Denis Kazyulkin, Pavel G Komarov, et al.
Scientific Reports|March 7, 2023
Histone H3-wild type diffuse midline gliomas with H3K27me3 loss are a distinct entity with exclusive EGFR or ACVR1 mutation and differential methylation of homeobox genesPamela Ajuyah, Chelsea Mayoh, Loretta M S Lau, et al.
Blood|April 5, 2024
Loss of the stress sensor GADD45A promotes stem cell activity and ferroptosis resistance in LGR4/HOXA9-dependent AMLNunki Hassan, Hangyu Yi, Bilal Malik, et al.
Leukemia|December 19, 2019
Effective targeting of NAMPT in patient-derived xenograft models of high-risk pediatric acute lymphoblastic leukemiaKlaartje Somers, Kathryn Evans, Leanna Cheung, et al.
Cancer Biology & Therapy|October 10, 2018
Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancerMaria Tsoli, Carol Wadham, Mark Pinese, et al.
Journal of the National Cancer Institute|July 30, 2011
ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug effluxMichelle J Henderson, Michelle Haber, Antonio Porro, et al.
Oncotarget|December 10, 2015
Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastomaAnneleen Decock, Maté Ongenaert, Robrecht Cannoodt, et al.
Frontiers in Oncology|June 9, 2022
The Combination of Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Delays KMT2A-Rearranged Leukemia ProgressionLin Xiao, Mawar Karsa, Emma Ronca, et al.
Cancer Research|December 15, 2018
Macrophage-Derived IL1β and TNFα Regulate Arginine Metabolism in NeuroblastomaLivingstone Fultang, Laura D Gamble, Luciana Gneo, et al.
Cancer Cytopathology|May 27, 2021
The important role of routine cytopathology in pediatric precision oncologyJinhan Xie, Amit Kumar, M Emmy M Dolman, et al.
Pageof 19